Anne Ghys
Beerse, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Week 96 resistance analyses of the once-daily, single-tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials.
Journal: Journal of medical virology
Published: June 23, 2020
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.
Journal: AIDS research and human retroviruses
Published: September 14, 2019
An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay.
Journal: Journal of clinical microbiology
Published: February 06, 2015
Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.
Journal: Antimicrobial agents and chemotherapy
Published: November 27, 2014
Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region.
Journal: Antiviral research
Published: September 25, 2014
Incidence of virological failure and emergence of resistance with twice-daily vs every 8-h administration of telaprevir in the OPTIMIZE study.
Journal: Journal of viral hepatitis
Published: June 24, 2014
Deep-sequencing analysis of the gene encoding the hepatitis C virus nonstructural 3-4A protease confirms a low prevalence of telaprevir-resistant variants at baseline and the end of the REALIZE study.
Journal: The Journal of infectious diseases
Published: June 20, 2014
Modeling viral evolutionary dynamics after telaprevir-based treatment.
Journal: PLoS computational biology
Published: January 21, 2014
Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir.
Journal: Virology journal
Published: December 17, 2013
Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: October 09, 2013
Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4: a randomized trial.
Journal: The Journal of infectious diseases
Published: June 27, 2013
Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 12, 2013
Last Updated: 09/26/2026